TRANSCUTANEOUS VAGUS NERVE STIMULATION IN POST-STROKE COGNITIVE IMPAIRMENT: NEUROPLASTICITY, BDNF, EEG BIOMARKERS, AND A PRECISION REHABILITATION FRAMEWORK

Authors

  • Davlatbayev Alisher Faxraddin o‘g‘li
  • Majidova Yoqutxon Nabiyevna

Keywords:

ischemic stroke, post-stroke cognitive impairment, transcutaneous auricular vagus nerve stimulation, taVNS, BDNF, electroencephalography, MoCA, Trail Making Test, neuroplasticity, neurorehabilitation

Abstract

Post-stroke cognitive impairment (PSCI) is a major determinant of long-term disability after ischemic stroke and may compromise independence even when motor recovery is relatively favorable. Transcutaneous auricular vagus nerve stimulation (taVNS) is an emerging non-invasive neuromodulation technique that activates vagal afferents projecting to the nucleus tractus solitarius and, through downstream noradrenergic and cholinergic systems, may facilitate experience-dependent plasticity, modulate neuroinflammation, and influence neurotrophic signaling. This narrative review examines the rationale for taVNS in PSCI with a specific focus on the late recovery period, 6-12 months after ischemic stroke. The review integrates direct cognitive evidence with the broader stroke-rehabilitation literature and proposes a multimodal response model combining cognitive outcomes (Montreal Cognitive Assessment and Trail Making Test), neurological deficit, functional independence, electroencephalographic dynamics, and serum brain-derived neurotrophic factor (BDNF). A randomized protocol specifically targeting PSCI has established the feasibility of an 8-week taVNS paradigm, while a 2024 DTI case report described improvement in global cognition and executive performance together with white-matter remodeling. More recent stroke trials and meta-analyses strengthen the biological plausibility of taVNS by demonstrating functional benefit, neurophysiological effects, and treatment-related changes in plasticity biomarkers including BDNF. Nevertheless, direct high-quality evidence for cognitive recovery after stroke remains limited, and stimulation parameters, patient selection, timing, and response biomarkers are not yet standardized. A precision-rehabilitation strategy based on convergent clinical, neuropsychological, EEG, and neurotrophic markers may therefore be a rational next step for clinical research.

References

Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8(11):1006-1018. doi:10.1016/S1474-4422(09)70236-4.

Mijajlovic MD, Pavlovic A, Brainin M, et al. Post-stroke dementia - a comprehensive review. BMC Med. 2017;15:11. doi:10.1186/s12916-017-0779-7.

Dawson J, Liu CY, Francisco GE, et al. Vagus nerve stimulation paired with rehabilitation for upper limb motor function after ischaemic stroke (VNS-REHAB): a randomised, blinded, pivotal, device trial. Lancet. 2021;397(10284):1545-1553. doi:10.1016/S0140-6736(21)00475-X.

Schambra HM, Hays SA. Vagus nerve stimulation for stroke rehabilitation: neural substrates, neuromodulatory effects and therapeutic implications. J Physiol. 2025;603(3):723-735. doi:10.1113/JP285566.

Wang L, Xu Q, Luo M, et al. Vagus nerve stimulation in various stages of stroke and associated functional impairments: a review. Neuroscience. 2025;577:80-113. doi:10.1016/j.neuroscience.2025.04.037.

Li ZD, Qiu HJ, Wang XQ, Zhang CC, Zhang YJ. Transcutaneous auricular vagus nerve stimulation in poststroke cognitive impairment: protocol for a randomised controlled trial. BMJ Open. 2022;12(10):e063803. doi:10.1136/bmjopen-2022-063803.

Chen X, Zhou Z, Chong K, et al. Transcutaneous auricular vagus nerve stimulation for long-term post-stroke cognitive impairment: a DTI case report. Front Hum Neurosci. 2024;18:1473535. doi:10.3389/fnhum.2024.1473535.

Wang W, Li R, Li C, Liang Q, Gao X. Advances in VNS efficiency and mechanisms of action on cognitive functions. Front Physiol. 2024;15:1452490. doi:10.3389/fphys.2024.1452490.

Liu F, Li Y. Sorting the mind: cognitive enhancement through transcutaneous auricular vagus nerve stimulation: a systematic review and meta-analysis. Psychol Med. 2026;56:e207. doi:10.1017/S0033291726105017.

de Melo PS, Parente J, Rebello-Sanchez I, et al. Understanding the neuroplastic effects of auricular vagus nerve stimulation in animal models of stroke: a systematic review and meta-analysis. Neurorehabil Neural Repair. 2023;37(8):564-576. doi:10.1177/15459683231177595.

Moustafa EBS, Darwish MH, El-Tamawy MS, et al. Plasticity biomarkers, interleukin 6, and motor performance responses to trans-auricular vagus nerve stimulation post-stroke: a randomized controlled trial. Am J Phys Med Rehabil. 2026;105(6):479-485. doi:10.1097/PHM.0000000000002878.

Baig SS, Dorney S, Aziz M, Bell SM, Ali AN, Su L, Redgrave JN, Majid A. Optimizing non-invasive vagus nerve stimulation for treatment in stroke. Neural Regen Res. 2025;20(12):3388-3399. doi:10.4103/NRR.NRR-D-24-00945.

Wan S, Liu X, Jiang W, Li Z, Yan Z, Li W, Yin Y. Effectiveness of transcutaneous auricular vagus nerve stimulation in stroke rehabilitation: a systematic review and meta-analysis of randomized clinical trials. Front Neurol. 2026;17:1786103. doi:10.3389/fneur.2026.1786103.

Zhang J, et al. Invasive or non-invasive vagus nerve stimulation modulation of brain function and remodeling after stroke: a review. Int J Surg. 2025;111(2):2148-2161. doi:10.1097/JS9.0000000000002173.

Downloads

Published

2026-11-06